CP-GEP Identifies High-Risk T1a Melanoma Patients Beyond Established Adverse Features. Yu WY, Pazhava A, Weitemeyer MB, Holmich LR, et al. J Am Acad Dermatol 2025 Oct 13:S0190-9622(25)03004.

Read + Share

Amedeo Smart

Independent Medical Education

Yu WY, Pazhava A, Weitemeyer MB, Holmich LR, et al. CP-GEP Identifies High-Risk T1a Melanoma Patients Beyond Established Adverse Features. J Am Acad Dermatol 2025 Oct 13:S0190-9622(25)03004.
PMID: 41093058